CRI New England to Implement OpenClinica Enterprise

(PRWEB) May 25, 2007 -- Akaza Research announces it is implementing OpenClinica Enterprise for use in clinical studies operated by the Community Research Initiative of New England (CRI). CRI will be using OpenClinica as a data management and study data capture platform for a number of its new HIV/AIDS clinical trials.

"As an organization conducting leading-edge HIV/AIDS clinical research everyday, we are excited by the potential for the OpenClinica system to help us more efficiently manage the enormous amount of clinical data we collect for each trial," says Julie Marston, CRI's Executive Director. "We believe OpenClinica Enterprise has the flexible and robust new tools we've been looking for to help us with our work. The scalability of this low-cost platform is ideally suited for the research data management needs of growing organizations like us."

About Community Research Initiative (CRI)
CRI is the only independent, nonprofit community-based organization in New England solely dedicated to HIV clinical research, treatment education, and financial assistance for approved drug treatments and health insurance coverage. The organization's mission is to lead the way in clinical HIV/AIDS research and to ensure access to life-saving drugs to those in need. For more information see http://www.crine.org.

About OpenClinica
OpenClinica is an open source, web-based software platform for managing clinical research. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a strictly standards-based, extensible, and modular platform. The current production release of OpenClinica is version 2.0.1. All versions of OpenClinica are available for download at www.OpenClinica.org.

About Akaza Research
Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based systems accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See www.akazaresearch.com.